Current prospects and future challenges for nasal vaccine delivery

Nasal delivery offers many benefits over traditional approaches to vaccine administration. These include ease of administration without needles that reduces issues associated with needlestick injuries and disposal. Additionally, this route offers easy access to a key part of the immune system that can stimulate other mucosal sites throughout the body. Increased acceptance of nasal vaccine products in both adults and children has led to a burgeoning pipeline of nasal delivery technology. Key challenges and opportunities for the future will include translating in vivo data to clinical outcomes. Particular focus should be brought to designing delivery strategies that take into account the broad range of diseases, populations and healthcare delivery settings that stand to benefit from this unique mucosal route

Systemic RALA/iNOS nanoparticles; a potent gene therapy for metastatic breast cancer coupled as a biomarker of treatment

This study aimed to determine the therapeutic benefit of a nanoparticular formulation for the delivery of inducible nitric oxide synthase (iNOS) gene therapy in a model of breast cancer metastasis. Nanoparticles comprising a cationic peptide vector, RALA, and plasmid DNA were formulated and characterized using a range of physiochemical analyses. Nanoparticles complexed using iNOS plasmids and RALA approximated 60 nm in diameter with a charge of 25 mV. A vector neutralization assay, performed to determine the immunogenicity of nanoparticles in immunocompetent C57BL/6 mice, revealed that no vector neutralization was evident. Nanoparticles harboring iNOS plasmids (constitutively active cytomegalovirus [CMV]-driven or transcriptionally regulated human osteocalcin [hOC]-driven) evoked iNOS protein expression and nitrite accumulation and impaired clonogenicity in the highly aggressive MDA-MB-231 human breast cancer model. Micrometastases of MDA-MB-231-luc-D3H1 cells were established in female BALB/c SCID mice by intracardiac delivery. Nanoparticulate RALA/CMV-iNOS or RALA/hOC-iNOS increased median survival in mice bearing micrometastases by 27% compared with controls and also provoked elevated blood nitrite levels. Additionally, iNOS gene therapy sensitized MDA-MB-231-luc-D3H1 tumors to docetaxel treatment. Studies demonstrated that systemically delivered RALA-iNOS nanoparticles have therapeutic potential for the treatment of metastatic breast cancer. Furthermore, detection of nitrite levels in the blood serves as a reliable biomarker of treatment. Keywords: nonviral gene therapy, nitric oxide, nanoparticle, breast cancer, metastasi

Development of A Method To Quantify The DNA Content in Cationic Peptide-DNA Nanoparticles

Gene therapy has the potential to provide safe and targeted therapies for a variety of diseases. A range of intracellular gene delivery vehicles have been proposed for this purpose. Non-viral vectors are a particularly attractive option and among them cationic peptides have emerged as promising candidates. For the pharmaceutical formulation and application to clinical studies it is necessary to quantify the amount of pDNA condensed with the delivery system. There is a severe deficiency in this area, thus far no methods have been reported specifically for pDNA condensed with cationic peptide to form nanoparticles. The current study seeks to address this and describes the evaluation of a range of disruption agents to extract DNA from nanoparticles formed by condensation with cationic fusogenic peptides RALA and KALA. Only proteinase K exhibited efficient and reproducible results and compatibility with the PicoGreen reagent based quantification assay. Thus we report for the first time a simple and reliable method that can quantify the pDNA content in pDNA cationic peptide nanoparticles

Aerosolised micro and nanoparticle: formulation and delivery method for lung imaging

PURPOSE: The application of contrast and tracing agents is essential for lung imaging, as indicated by the wide use in recent decades and the discovery of various new contrast and tracing agents. Different aerosol production and pulmonary administration methods have been developed to improve lung imaging quality. This review details and discusses the ideal characteristics of aerosol administered via pulmonary delivery for lung imaging and the methods for the production and pulmonary administration of dry or liquid aerosol. METHODS: We explored several databases, including PubMed, Scopus, and Google Scholar, while preparing this review to discover and obtain the abstracts, reports, review articles, and research papers related to aerosol delivery for lung imaging and the formulation and pulmonary delivery method of dry and liquid aerosol. The search terms used were “dry aerosol delivery”, “liquid aerosol delivery”, “MRI for lung imaging”, “CT scan for lung imaging”, “SPECT for lung imaging”, “PET for lung imaging”, “magnetic particle imaging”, “dry powder inhalation”, “nebuliser”, and “pressurised metered-dose inhaler”. RESULTS: Through the literature review, we found that the critical considerations in aerosol delivery for lung imaging are appropriate lung deposition of inhaled aerosol and avoiding toxicity. The important tracing agent was also found to be Technetium-99m ((99m)Tc), Gallium-68 ((68)Ga) and superparamagnetic iron oxide nanoparticle (SPION), while the essential contrast agents are gold, iodine, silver gadolinium, iron and manganese-based particles. The pulmonary delivery of such tracing and contrast agents can be performed using dry formulation (graphite ablation, spark ignition and spray dried powder) and liquid aerosol (nebulisation, pressurised metered-dose inhalation and air spray). CONCLUSION: A dual-imaging modality with the combination of different tracing or contrast agents is a future development of aerosolised micro and nanoparticles for lung imaging to improve diagnosis success. GRAPHICAL ABSTRACT: [Image: see text

Stoichiometry related phenomena in low temperature grown GaAs

Full text of this item is not available in the UHRAIn this study the nature of the interaction between Tween-20 and lactate dehydrogenase (LDH) was investigated using isothermal titration calorimetry (ITC). In addition the effects of the protein and surfactant on the interfacial properties were followed with interfacial rheology and surface tension measurements in order to understand the mechanism by which the surfactant prevents protein adsorption to the air-water interface. Comparisons were made with Tween-40 and Tween-80 in order to further investigate the mechanism. ITC measurements indicated a weak, probably hydrophobic, interaction between Tween-20 and LDH. Prevention of LDH adsorption to the air-water interface by the Tween surfactants was correlated with Surface energy rather than surfactant CMC. While surface pressure appears to be the main driving force for the displacement of LDH from the air-water interface by Tween-20 a solubilisation mechanism may exist for other protein molecules. More generally the results of this study highlight the value of the use of ITC and interfacial measurements in characterising the surface behaviour of mixed surfactant and protein systems. (C) 2009 Wiley-Liss, Inc. and the American Pharmacists Association J Pharm Sci 98:2659-2669, 2009Peer reviewe

An investigation into the crystallization of alpha,alpha-trehalose from the amorphous state

The nonisothermal behavior of amorphous alpha,alpha-trehalose has been studied in order to identify the factors influencing the recrystallization process. Particular emphasis has been placed on examining the effect of differential scanning calorimetry (DSC) pan type and initial water content on the thermal response. Samples of freeze-dried trehalose with water levels up to 6% w/w were sealed in pinholed and hermetically sealed pans and analyzed using DSC at a scanning rate of 10 degreesC/min in conjunction with thermogravimetric analysis (TGA), with the dihydrate studied in pinholed pans for comparison. The dihydrate was found to exhibit two endotherms at ca. 100 degreesC and 122 degreesC, followed by a further endotherm at 211 degreesC that was attributed to melting of the anhydrate. Isolation of the material following the first endotherm indicated that the material generated at this temperature was the T-gamma form. Amorphous material heated in pinholed pans exhibited an exotherm at ca. 100-150 degreesC (the value depending on water content) when the initial water levels were 4.1% or below. This response was accompanied by dehydration and was attributed to the formation of the crystalline anhydrate. Higher water content samples, however, showed an exotherm followed immediately by an endotherm, with the water loss taking place in two distinct stages. XRD studies indicated that these samples initially crystallized into the T-gamma form, followed by subsequent dehydration to the anhydrate. Samples analyzed in hermetically sealed pans showed a single exotherm between 100 and 150 degreesC followed by a broad endotherm between 150 and 200 degreesC, with higher water content samples having lower values for both events. XRD indicated that the exotherm and endotherm corresponded to the formation and fusion of the T-gamma form, respectively. The study has therefore shown that the recrystallization behavior of amorphous trehalose is dependent on both the initial water content and the environment in which recrystallization takes place

Spray Congealed Lipid Microparticles with High Protein Loading: Preparation and Solid State Characterization

The spray congealing technique, a solvent-free drug encapsulation process, was succesfuly employed to obtain lipid-based particulate systems with high (10-20% w/w) protein loading. Bovine serum albumine (BSA) was utilised as model protein and three low melting lipids (glyceryl palmitostearate, trimirystin and tristearin) were employed as carriers. BSA-loaded lipid microparticles were characterized in terms of particle size, morphology and drug loading. The results showed that the microparticles exhibited a spherical shape, mean diameter in the range 150-300 mm and an encapsulation efficiency higher than 90%. Possible changes in the protein structure as a result of the manufacturing process was then investigated for the first time using UV spectrophotometry in fourth derivative mode and FT-Raman spectroscopy. The results suggested that the structural integrity of the protein was maintained within the particles. Thermal analysis indicated that the effect of protein on the thermal properties of the carriers could be detected. Spray congealing could thus be considered a suitable technique to produce highly BSA loaded microparticles preserving the structure of the protein

Development of a Spray-Dried Formulation of Peptide-Dna Nanoparticles into a Dry Powder for Pulmonary Delivery Using Factorial Design

BACKGROUND: Gene therapy via pulmonary delivery holds the potential to treat various lung pathologies. To date, spray drying has been the most promising method to produce inhalable powders. The present study determined the parameters required to spray dry nanoparticles (NPs) that contain the delivery peptide, termed RALA (N-WEARLARALARALARHLARALARALRACEA-C), complexed with plasmid DNA into a dry powder form designed for inhalation. METHODS: The spray drying process was optimised using full factorial design with 19 randomly ordered experiments based on the combination of four parameters and three centre points per block. Specifically, mannitol concentration, inlet temperature, spray rate, and spray frequency were varied to observe their effects on process yield, moisture content, a median of particle size distribution, Z-average, zeta potential, encapsulation efficiency of DNA NPs, and DNA recovery. The impact of mannitol concentration was also examined on the spray-dried NPs and evaluated via biological functionality in vitro. RESULTS: The results demonstrated that mannitol concentration was the strongest variable impacting all responses apart from encapsulation efficiency. All measured responses demonstrated a strong dependency on the experimental variables. Furthermore, spray drying with the optimal variables in combination with a low mannitol concentration (1% and 3%, w/v) produced functional RALA/pDNA NPs. CONCLUSION: The optimal parameters have been determined to spray dry RALA/pDNA NPs into an dry powder with excellent biological functionality, which have the potential to be used for gene therapy applications via pulmonary delivery

Novel freeze-dried DDA and TPGS liposomes are suitable for nasal delivery of vaccine

There is a pressing need for effective needle-free vaccines that are stable enough for use in the developing world and stockpiling. The inclusion of the cationic lipid DDA and the PEG-containing moiety TPGS into liposomes has the potential to improve mucosal delivery. The aim of this study was to develop stable lyophilized cationic liposomes based on these materials suitable for nasal antigen delivery. Liposomes containing DDA and TPGS were developed. Size and zeta potential measurements, ex vivo, CLSM cell penetration study and cell viability investigations were made. Preliminary immunisation and stability studies using ovalbumin were performed. The liposomes exhibited suitable size and charge for permeation across nasal mucosa. DDA and TPGS increased tissue permeation in ex vivo studies and cell uptake with good cell viability. The liposomes improved immune response both locally and vaginally when compared to i.m administration or control liposomes delivered nasally. Additionally, the lyophilized products demonstrated good stability in terms of Tg, size and antigen retention. This study has shown that the novel liposomes have potential for development as a mucosal vaccine delivery system. Furthermore, the stability of the lyophilized liposomes offers potential additional benefits in terms of thermal stability over liquid formats

An evaluation of the use of modulated temperature DSC as a means of assessing the relaxation behaviour of amorphous lactose

Purpose. To evaluate the use of Modulated Temperature DSC (MTDSC) as a means of assessing the relaxation behaviour of amorphous lactose via measurement of the heat capacity, glass transition (Tg) and relaxation endotherm. Methods. Samples of amorphous lactose were prepared by freeze drying. MTDSC was conducted using a TA Instruments 2920 MDSC using a heating rate of 2 degrees C/minute, a modulation amplitude of +/-0.3 degrees C and a period of 60 seconds. Samples were cycled by heating to 140 degrees C and cooling to a range of annealing temperatures between 80 degrees C and 100 degrees C, followed by reheating through the Tg region. Systems were then recooled to allow for correction of the Tg shift effect. Results. MTDSC enabled separation of the glass transition from the relaxation endotherm, thereby facilitating calculation of the relaxation time as a function of temperature. The relative merits of using MTDSC for the assessment of relaxation processes are discussed. In addition, the use of the fictive temperature rather than the experimentally derived Tg is outlined. Conclusions. MTDSC allows assessment of the glass transition temperature, the magnitude of the relaxation endotherm and the value of the heat capacity, thus facilitating calculation of relaxation times. Limitations identified with the approach include the slow scanning speed, the need for careful choice of experimental parameters and the Tg shift effect